Prenatal antidepressant use and risk of autism spectrum disorders in children

JAMA Pediatrics

Volumn 170, Issue 7, 2016, Pages 712-

  Kaplan, Yusuf Cem ^a,b   Keskin Arslan, Elif ^a   Acar, Selin ^a  

^a IZMIR KATIP CELEBI UNIVERSITY   (Turkey)

^b ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

AUTISM; HUMAN; LETTER; PRENATAL EXPOSURE; PRIORITY JOURNAL; PUERPERAL DEPRESSION; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; CHILD; RISK;

ANTIDEPRESSIVE AGENTS; AUTISM SPECTRUM DISORDER; CHILD; HUMANS; PRENATAL EXPOSURE DELAYED EFFECTS; RISK;

EID: 84978175926     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2016.0727     Document Type: Letter

References (5)

1. Boukhris T, Sheehy O, Mottron L, Bérard A. Antidepressant use during pregnancy and the risk of autism spectrum disorder in children. JAMA Pediatr. 2016;170(2):117-124
2. Hviid A, Melbye M, Pasternak B. Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. N Engl J Med. 2013;369(25): 2406-2415.
3. Sørensen MJ, Grønborg TK, Christensen J, et al. Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clin Epidemiol. 2013;5:449-459.
4. El Marroun H, White TJ, van der Knaap NJ, et al. Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children. Br J Psychiatry. 2014;205(2): 95-102.
5. Harrington RA, Lee LC, Crum RM, Zimmerman AW, Hertz-Picciotto I. Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy. Autism Res. 2013;6(3):149-168.